Cancer Consult – Expertise in Clinical Practice, Second Edition. Volume 2 – Neoplastic Hematology & Cell Therapy
Autor SA Abutaliben Limba Engleză Paperback – 14 dec 2023
Preț: 660.07 lei
Preț vechi: 933.53 lei
-29% Nou
Puncte Express: 990
Preț estimativ în valută:
126.32€ • 130.76$ • 106.77£
126.32€ • 130.76$ • 106.77£
Carte nepublicată încă
Doresc să fiu notificat când acest titlu va fi disponibil:
Se trimite...
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9781119823124
ISBN-10: 1119823129
Pagini: 864
Dimensiuni: 171 x 244 x 50 mm
Greutate: 1.36 kg
Editura: Wiley
Locul publicării:Chichester, United Kingdom
ISBN-10: 1119823129
Pagini: 864
Dimensiuni: 171 x 244 x 50 mm
Greutate: 1.36 kg
Editura: Wiley
Locul publicării:Chichester, United Kingdom
Notă biografică
Syed A. Abutalib, MD, is Co-Director of Hematology and Stem Cell Transplantation and Clinical Director of NMDP(R) Apheresis Center at the Midwest Branch of Cancer Treatment Centers of America, (CTCA), Part of City of Hope.
Maurie Markman, MD, is President of Medicine & Science, Cancer Treatment Centers of America, Part of City of Hope.
James O. Armitage, MD, is the Joe Shapiro Professor of Medicine at University of Nebraska Medical Center and has served as Dean for College of Medicine and Chairman of Internal Medicine. He is past President of both the ASCO and the ASTCT.
Kenneth C. Anderson, MD, is the Kraft Family Professor of Medicine at Harvard Medical School, as well as Director of the LeBow Institute for Myeloma Therapeutics and Jerome Lipper Multiple Myeloma Center at Dana-Farber Cancer Institute. He is past President of ASH.
Maurie Markman, MD, is President of Medicine & Science, Cancer Treatment Centers of America, Part of City of Hope.
James O. Armitage, MD, is the Joe Shapiro Professor of Medicine at University of Nebraska Medical Center and has served as Dean for College of Medicine and Chairman of Internal Medicine. He is past President of both the ASCO and the ASTCT.
Kenneth C. Anderson, MD, is the Kraft Family Professor of Medicine at Harvard Medical School, as well as Director of the LeBow Institute for Myeloma Therapeutics and Jerome Lipper Multiple Myeloma Center at Dana-Farber Cancer Institute. He is past President of ASH.